CJC-1295 + Ipamorelin combines two compounds that act through distinct components of the growth-hormone regulatory system. CJC-1295 is a growth hormone-releasing hormone analogue, while ipamorelin is a selective growth-hormone secretagogue and ghrelin-receptor agonist. The blend is used in research examining complementary pituitary signaling, growth-hormone pulse dynamics, downstream IGF-1 responses and interactions between GHRH and GHS-R1a pathways. Applications may include receptor assays, endocrine biomarker measurement, comparative secretagogue studies and preclinical body-composition or muscle-function models. Evidence for the combined product is more limited than the literature on each component individually, so researchers should avoid assuming synergy and should verify the exact ratio and identity of both peptides on the batch CoA.
For laboratory research use only. Not for human or veterinary use. This description is informational and does not provide medical advice, dosing, or treatment guidance.
Reviews
There are no reviews yet.